Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SAMMY ELMARIAH

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1659350858
CMS profile
255947
Location
SAN FRANCISCO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$27,091.13

51 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Edwards Lifesciences Corporation $26,648.90 45
Medtronic, Inc. $405.50 5
Abbott Laboratories $36.73 1

Page 2 of 2; records 51–51 of 51 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SAMMY ELMARIAH

NPI 1659350858 · CMS profile ID 255947

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

SAN FRANCISCO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–51 of 51 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1659350858?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SAMMY ELMARIAH, NPI 1659350858, CMS profile ID 255947. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–51 of 51 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1659350858?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SAMMY ELMARIAH, NPI 1659350858, CMS profile ID 255947. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–51 of 51 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1659350858?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SAMMY ELMARIAH, NPI 1659350858, CMS profile ID 255947, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–51 of 51 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1659350858?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

51 matching records · $27,091.13 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 51 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–51 of 51.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Edwards Lifesciences Corporation $1,718.7501/04/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138818785 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,124.97 13
PY2020 $2,059.20 15
PY2021 $11,392.76 37
PY2022 $15,879.33 41
PY2023 $41,279.53 80
PY2024 $27,091.13 51
PY2025 $27,029.20 52

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $664,898.22 86
PY2024 Principal investigator $984,282.28 99
PY2023 Principal investigator $1,034,842.05 57
PY2022 Principal investigator $521,679.20 39
PY2021 Principal investigator $476,073.67 36
PY2020 Principal investigator $214,022.43 12
PY2019 Principal investigator $160,000.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

86 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Medtronic, Inc. $7,584.31 12/31/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
SPYRAL AFFIRM No dispute reported 06/30/2026 1185005551
Principal investigator 1 W. L. Gore & Associates, Inc. $3,120.00 12/31/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study No dispute reported 06/30/2026 1181947602
Principal investigator 1 W. L. Gore & Associates, Inc. $3,883.60 12/24/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study No dispute reported 06/30/2026 1181947600
Principal investigator 1 Edwards Lifesciences Corporation $6,408.07 12/19/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
TRISCEND II Pivotal (2020-05) No dispute reported 06/30/2026 1222704410
Principal investigator 1 Medtronic, Inc. $156.00 12/19/2025 Non-covered Recipient Entity
Regents Of The University Of California San Francisco
SPYRAL AFFIRM No dispute reported 06/30/2026 1192330785
Principal investigator 1 Abbott Laboratories $998.00 12/17/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248160932
Principal investigator 1 Edwards Lifesciences Corporation $59,498.11 12/05/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704408
Principal investigator 1 Abbott Laboratories $2,090.00 11/28/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248160180
Principal investigator 1 Edwards Lifesciences Corporation $5,845.35 11/28/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704406
Principal investigator 1 Abbott Laboratories $867.58 11/26/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248160062
Principal investigator 1 Abbott Laboratories $1,242.22 11/24/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248159928
Principal investigator 1 Abbott Laboratories $624.00 11/19/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248159646
Principal investigator 1 Edwards Lifesciences Corporation $3,192.00 11/14/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704400
Principal investigator 1 Edwards Lifesciences Corporation $3,231.90 11/14/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704402
Principal investigator 1 Edwards Lifesciences Corporation $2,604.14 11/07/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
TRISCEND II Pivotal (2020-05) No dispute reported 06/30/2026 1222704404
Principal investigator 1 Abbott Laboratories $4,488.75 11/03/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation No dispute reported 06/30/2026 1248158952
Principal investigator 1 W. L. Gore & Associates, Inc. $400.00 10/31/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study No dispute reported 06/30/2026 1181947592
Principal investigator 1 Edwards Lifesciences Corporation $393.28 10/30/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
ALTERRA Early Feasibility (2016-04) No dispute reported 06/30/2026 1222704396
Principal investigator 1 Edwards Lifesciences Corporation $7,926.60 10/23/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704394
Principal investigator 1 Edwards Lifesciences Corporation $2,525.70 10/06/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP IIF (2018-07) No dispute reported 06/30/2026 1222704392
Principal investigator 1 Edwards Lifesciences Corporation $385.70 10/02/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704384
Principal investigator 1 Edwards Lifesciences Corporation $6,591.24 10/02/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704386
Principal investigator 1 Edwards Lifesciences Corporation $4,000.00 10/02/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704388
Principal investigator 1 Edwards Lifesciences Corporation $432.25 10/02/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704390
Principal investigator 1 Edwards Lifesciences Corporation $61.18 09/25/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
ALTERRA Early Feasibility (2016-04) No dispute reported 06/30/2026 1222704380
Principal investigator 1 Edwards Lifesciences Corporation $771.40 09/25/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704382
Principal investigator 1 Edwards Lifesciences Corporation $59.60 09/19/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704378
Principal investigator 1 Edwards Lifesciences Corporation $99.00 09/18/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704376
Principal investigator 1 Edwards Lifesciences Corporation $7,980.00 09/17/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
JOURNEY (Trial JCM-002) No dispute reported 06/30/2026 1222704374
Principal investigator 1 Edwards Lifesciences Corporation $8,120.98 08/28/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704372
Principal investigator 1 Abbott Laboratories $5,018.05 08/18/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248155594
Principal investigator 1 Medtronic, Inc. $23,015.90 08/15/2025 Non-covered Recipient Entity
Regents Of The University Of California San Francisco
SPYRAL AFFIRM No dispute reported 06/30/2026 1192330783
Principal investigator 1 Abbott Laboratories $293.93 08/11/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248155336
Principal investigator 1 Abbott Laboratories $600.00 07/31/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248153580
Principal investigator 1 Edwards Lifesciences Corporation $3,285.89 07/31/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
TRISCEND II Pivotal (2020-05) No dispute reported 06/30/2026 1222704370
Principal investigator 1 Edwards Lifesciences Corporation $3,016.70 07/17/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial 2021-01 No dispute reported 06/30/2026 1222704366
Principal investigator 1 Edwards Lifesciences Corporation $1,542.80 07/10/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial 2021-01 No dispute reported 06/30/2026 1222704360
Principal investigator 1 Edwards Lifesciences Corporation $1,170.40 07/10/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704362
Principal investigator 1 Edwards Lifesciences Corporation $4,761.20 07/10/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
COMPASSION S3 2015-01 No dispute reported 06/30/2026 1222704364
Principal investigator 1 Edwards Lifesciences Corporation $7,141.90 07/07/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial 2021-01 No dispute reported 06/30/2026 1222704354
Principal investigator 1 Edwards Lifesciences Corporation $771.40 07/07/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
TRISCEND II Pivotal (2020-05) No dispute reported 06/30/2026 1222704356
Principal investigator 1 Edwards Lifesciences Corporation $791.80 06/30/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial 2021-01 No dispute reported 06/30/2026 1222704350
Principal investigator 1 Edwards Lifesciences Corporation $22,556.14 06/30/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704352
Principal investigator 1 Abbott Laboratories $12,118.82 06/25/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248152166
Principal investigator 1 W. L. Gore & Associates, Inc. $2,088.10 06/19/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study No dispute reported 06/30/2026 1181947584
Principal investigator 1 Abbott Laboratories $13,300.00 06/12/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation No dispute reported 06/30/2026 1248151830
Principal investigator 1 Edwards Lifesciences Corporation $14,145.21 06/05/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial 2021-01 No dispute reported 06/30/2026 1222704344
Principal investigator 1 Abbott Laboratories $2,000.00 06/03/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248151544
Principal investigator 1 Edwards Lifesciences Corporation $7,724.77 05/27/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP IIF (2018-07) No dispute reported 06/30/2026 1222704340
Principal investigator 1 Edwards Lifesciences Corporation $768.46 05/22/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
ALTERRA Early Feasibility (2016-04) No dispute reported 06/30/2026 1222704338
Principal investigator 1 Abbott Laboratories $293.93 05/21/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248151236
Principal investigator 1 Abbott Laboratories $1,023.00 05/13/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248150910
Principal investigator 1 Edwards Lifesciences Corporation $34,455.53 05/05/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704336
Principal investigator 1 Edwards Lifesciences Corporation $1,288.41 05/01/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704330
Principal investigator 1 Edwards Lifesciences Corporation $14,294.97 05/01/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704332
Principal investigator 1 Edwards Lifesciences Corporation $2,394.00 05/01/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
TRISCEND II Pivotal (2020-05) No dispute reported 06/30/2026 1222704334
Principal investigator 1 Edwards Lifesciences Corporation $4,601.80 04/24/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
TRISCEND II Pivotal (2020-05) No dispute reported 06/30/2026 1222704326
Principal investigator 1 Edwards Lifesciences Corporation $2,473.80 04/24/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial 2021-01 No dispute reported 06/30/2026 1222704328
Principal investigator 1 Edwards Lifesciences Corporation $118,146.00 04/09/2025 Covered Recipient Teaching Hospital
Massachusetts General Hospital
Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: The DETECT AS Trial. No dispute reported 06/30/2026 1222703938
Principal investigator 1 Edwards Lifesciences Corporation $36,331.36 04/03/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
The PROGRESS Trial – Continued Access 2021-01-CAP No dispute reported 06/30/2026 1222704316
Principal investigator 1 Edwards Lifesciences Corporation $5,379.98 04/03/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
ALTERRA Early Feasibility (2016-04) No dispute reported 06/30/2026 1222704318
Principal investigator 1 Edwards Lifesciences Corporation $112,924.50 03/25/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
Utilization of AVR for Symptomatic Severe AS Across California No dispute reported 06/30/2026 1222704314
Principal investigator 1 W. L. Gore & Associates, Inc. $13,467.58 03/24/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study No dispute reported 06/30/2026 1181947582
Principal investigator 1 Abbott Laboratories $500.00 03/18/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248147758
Principal investigator 1 Medtronic, Inc. $159.91 03/13/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
SPYRAL AFFIRM No dispute reported 06/30/2026 1185005709
Principal investigator 1 Edwards Lifesciences Corporation $931.00 03/06/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
COMPASSION S3 2015-01 No dispute reported 06/30/2026 1222704312
Principal investigator 1 Abbott Laboratories $1,972.00 02/26/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248147068
Principal investigator 1 Abbott Laboratories $9,203.91 02/24/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248147042
Principal investigator 1 Edwards Lifesciences Corporation $1,084.72 02/24/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP IIF (2018-07) No dispute reported 06/30/2026 1222704310
Principal investigator 1 Abbott Laboratories $159.00 02/21/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248146882
Principal investigator 1 Edwards Lifesciences Corporation $478.80 02/14/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
ALTERRA Early Feasibility (2016-04) No dispute reported 06/30/2026 1222704306
Principal investigator 1 Abbott Laboratories $1,249.00 02/12/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248146234
Principal investigator 1 Edwards Lifesciences Corporation $23,454.56 02/04/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
CLASP II TR Pivotal, Study No. 2019-07 No dispute reported 06/30/2026 1222704302
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145078
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145080
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145082
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145090
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145098
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145100
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145104
Principal investigator 1 Abbott Laboratories $159.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248145110
Principal investigator 1 W. L. Gore & Associates, Inc. $2,781.03 01/17/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study No dispute reported 06/30/2026 1181947578
Principal investigator 1 Novartis Pharmaceuticals Corporation $25.10 01/15/2025 Non-covered Recipient Entity
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER AT MOUNT ZION
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS] No dispute reported 06/30/2026 1190304209
Principal investigator 1 W. L. Gore & Associates, Inc. $400.00 01/10/2025 Covered Recipient Teaching Hospital
Ucsf Medical Center
GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study No dispute reported 06/30/2026 1181947580
Principal investigator 1 Edwards Lifesciences Corporation $2,300.90 01/09/2025 Covered Recipient Teaching Hospital
Langley Porter Psychiatric Hospital
TRISCEND II Pivotal (2020-05) No dispute reported 06/30/2026 1222704298
Principal investigator 1 Abbott Laboratories $159.00 01/08/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04198870--MitraClip REPAIR MR Study No dispute reported 06/30/2026 1248144610